Pancreatic-derived factor promotes lipogenesis in the mouse liver: Role of the Forkhead box 1 signaling pathway
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pancreatic-derived factor promotes lipogenesis in the mouse liver: Role of the Forkhead box 1 signaling pathway
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 53, Issue 6, Pages 1906-1916
Publisher
Wiley
Online
2011-03-15
DOI
10.1002/hep.24295
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FoxO1 integrates insulin signaling to VLDL production
- (2011) Adama Kamagate et al. CELL CYCLE
- Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Musso et al. Annual Review of Medicine
- Targeted Disruption of Pancreatic-Derived Factor (PANDER, FAM3B) Impairs Pancreatic -Cell Function
- (2010) C. E. Robert-Cooperman et al. DIABETES
- Liver-Specific Overexpression of Pancreatic-Derived Factor (PANDER) Induces Fasting Hyperglycemia in Mice
- (2010) Camella G. Wilson et al. ENDOCRINOLOGY
- Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection
- (2010) Brad Q. Starley et al. HEPATOLOGY
- Hepatic FoxO1 Ablation Exacerbates Lipid Abnormalities during Hyperglycemia
- (2010) Rebecca A. Haeusler et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pathology of nonalcoholic fatty liver disease
- (2010) Elizabeth M. Brunt Nature Reviews Gastroenterology & Hepatology
- Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis
- (2010) Shijie Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
- (2009) Bei B. Zhang et al. Cell Metabolism
- The role of FOXO in the regulation of metabolism
- (2009) Danielle N. Gross et al. Current Diabetes Reports
- FoxO1 Haploinsufficiency Protects Against High-Fat Diet-Induced Insulin Resistance With Enhanced Peroxisome Proliferator-Activated Receptor Activation in Adipose Tissue
- (2009) J. J. Kim et al. DIABETES
- PANDER binds to the liver cell membrane and inhibits insulin signaling in HepG2 cells
- (2009) Jichun Yang et al. FEBS LETTERS
- Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications
- (2009) Elisa Fabbrini et al. HEPATOLOGY
- Hepatic Steatosis in Leptin-Deficient Mice Is Promoted by the PPARγ Target Gene Fsp27
- (2008) Kimihiko Matsusue et al. Cell Metabolism
- Inactivation of Hepatic Foxo1 by Insulin Signaling Is Required for Adaptive Nutrient Homeostasis and Endocrine Growth Regulation
- (2008) Xiaocheng C. Dong et al. Cell Metabolism
- Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis
- (2008) L. Valenti et al. DIABETES
- Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice
- (2008) Qiong Wang et al. HEPATOLOGY
- Peroxisome proliferator-activated receptor-δ induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice
- (2008) Xiaomei Qin et al. HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now